Investor Relations Home

2014 Annual Report
2014 Annual Report
2012 Annual Report
2012 Annual Report
2011 Annual Report
2011 Annual Report
2009 Annual Report
2009 Annual Report
2008 Annual Report
2008 Annual Report
2007 Annual Report
2007 Annual Report
  
Stock Quote
MASI (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$49.02
Change (%) Stock is Down 0.33 (0.67%)
Volume79,998
Data as of 05/26/16 12:01 p.m. ET
Minimum 20 minute delay
Refresh quote
Online Investor Kit
Masimo Reports First Quarter 2016 Financial Results
2015 Form 10K
2016 Proxy Statement
2014 Annual Report
Corporate Profile
We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... 
More >>
Upcoming EventsMore >>
There are currently no events scheduled.
Recent News
RSS Feeds RSS
| More >>
Masimo to Showcase Next Generation SedLine® Brain Function Monitor at 2016 Euroanaesthesia Congress - 05/26/16
SedLine, Which Helps Clinicians Improve Anesthetic Management, Receives CE Mark NEUCHATEL, Switzerland--(BUSINESS WIRE)--May 26, 2016-- Masimo (NASDAQ: MASI) announced today the CE mark and scheduled full market ... More >>
Two Fire Departments Honored for Excellence in Emergency Medical Services - 05/19/16
Fire-Service Based EMS Awards Presented at 28th Annual National Fire and Emergency Services Dinner WASHINGTON & IRVINE, Calif.--(BUSINESS WIRE)--May 19, 2016-- The Congressional Fire Services Institute (CFSI) and Masimo ... More >>
Masimo Reports First Quarter 2016 Financial Results - 05/04/16
Q1 2016 Highlights (compared to Q1 2015): Total revenue, including royalties, rose 10.8% to $171.2 million Product revenue rose 10.8% to $163.3 million Masimo rainbow® revenue... More >>
One of France’s University Hospitals Adopts Masimo Radical-7®, Including SpHb®, PVI®, and SET® Pulse Oximetry - 04/21/16
NEUCHÂTEL, Switzerland--(BUSINESS WIRE)--Apr. 21, 2016-- Masimo (NASDAQ: MASI) announced today that Centre Hospitalier Universitaire (CHU) de Limoges, in Limoges, France has installed Masimo’s Radical-7®, including noninva... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Masimo Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 

To request a copy of the Annual Report, click here.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.